Article
The C677T methylenetetrahydrofolate reductase polymorphism influences the homocysteine-lowering effect of hormone replacement therapy.
Molecular genetics and metabolism - 1 May 1999
Brown C A, McKinney K Q, Young K B, Norton H J
Abstract excerpt
Elevated homocysteine is an independent risk factor for cardiovascular disease and has been associated with a common C677T polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene. Estrogen use has been shown to reduce homocysteine concentrations, suggesting that this might contribute to the cardiovascular benefit of hormone replacement therapy. We examined 90 postmenopausal women to determine if...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
